XML 40 R28.htm IDEA: XBRL DOCUMENT v3.22.0.1
Fair Value of Financial Instruments (Tables)
12 Months Ended
Dec. 31, 2021
Fair Value of Financial Instruments  
Summary of marketable securities portfolio

The following is a summary of our marketable security portfolio for the periods presented (in thousands):

Net

Net

Amortized

Unrealized

Unrealized

Estimated

    

Cost

    

Gains

    

Losses

    

Fair Value

 

December 31, 2021

    

    

    

    

Debt securities (government)

$

291,871

$

$

(1,119)

$

290,752

December 31, 2020

Debt securities (government)

$

288,199

$

170

$

$

288,369

Schedule of fair value of assets measured on recurring basis

The following fair value hierarchy table presents information about each major category of our financial assets measured at fair value on a recurring basis (in thousands):

Fair Value Measurement at Reporting Date Using:

Quoted Prices in

Significant Other

Significant

Active Markets for

Observable

Unobservable

Identical Assets

Inputs

Inputs

Balance as of

    

(Level 1)

    

(Level 2)

    

(Level 3)

    

December 31, 2021

 

Cash and cash equivalents

$

2,057,440

$

$

$

2,057,440

Debt securities (government)

 

 

290,752

 

 

290,752

Long term investments (Note 6)

 

221,266

 

 

 

221,266

Total assets

$

2,278,706

$

290,752

$

$

2,569,458

Fair Value Measurement at Reporting Date Using:

Quoted Prices in

Significant Other

Significant

Active Markets for

Observable

Unobservable

Identical Assets

Inputs

Inputs

Balance as of

    

(Level 1)

    

(Level 2)

    

(Level 3)

    

December 31, 2020

 

Cash and cash equivalents

$

1,513,008

$

$

$

1,513,008

Debt securities (government)

 

288,369

 

288,369

Long term investments (Note 6)

 

222,301

 

 

 

222,301

Total assets

$

1,735,309

$

288,369

$

$

2,023,678

Schedule of fair value of liabilities measured on recurring basis

The following fair value hierarchy table presents information about each major category of our financial liabilities measured at fair value on a recurring basis (in thousands):

Fair Value Measurement at Reporting Date Using:

Quoted Prices in

Significant Other

Significant

Active Markets for

Observable

Unobservable

                                

Identical Liabilities

Inputs

Inputs

Balance as of

    

(Level 1)

    

(Level 2)

    

(Level 3)

    

December 31, 2021

Acquisition-related contingent consideration

$

$

$

244,000

$

244,000

Total liabilities

$

$

$

244,000

$

244,000

Fair Value Measurement at Reporting Date Using:

Quoted Prices in

Significant Other

Significant

Active Markets for

Observable

Unobservable

Identical Liabilities

Inputs

Inputs

Balance as of

    

(Level 1)

    

(Level 2)

    

(Level 3)

    

December 31, 2020

Acquisition-related contingent consideration

$

$

$

266,000

$

266,000

Total liabilities

$

$

$

266,000

$

266,000

Schedule of roll forward of Level 3 liabilities

The following is a roll forward of our Level 3 liabilities (in thousands):

2021

2020

Balance at January 1,

$

266,000

$

277,000

Contingent consideration earned during the period but not yet paid

(19,583)

(9,595)

Payments made during the period

(17,158)

(24,790)

Change in fair value of contingent consideration

14,741

23,385

Balance at December 31,

$

244,000

$

266,000